Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
38.54
+1.30 (3.49%)
At close: Jul 2, 2026, 4:00 PM EDT
38.60
+0.06 (0.16%)
After-hours: Jul 2, 2026, 6:29 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.41 billion as of July 2, 2026. Its market cap has increased by 1,187.98% in one year.
Market Cap
2.41B
Enterprise Value
2.29B
1-Year Change
1,187.98%
Ranking
Category
Stock Price
$38.54
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.41B, an increase of 572.88%. That is a compound annual growth rate of 27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.41B | 38.88% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.47B |
| SELLAS Life Sciences Group | 2.47B |
| Immunome | 2.43B |
| Intellia Therapeutics | 2.41B |
| Biohaven | 2.37B |
| Pharvaris | 2.37B |
| Mineralys Therapeutics | 2.37B |
| AbCellera Biologics | 2.32B |